Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH.

Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

LATEST FROM THE BLOG

In Brief: The Complex Relationship Between Endometriosis and Depression

MGH Center for Women's Mental Health2019-09-18T18:01:50-04:00September 12th, 2019|

A meta-analysis of 24 studies, including 99,614 women, demonstrated higher levels of depression among women with endometriosis compared to unaffected controls. When researchers […]

Register Online MGH Conference on Women’s Mental Health – October 17, 2019

MGH Center for Women's Mental Health2019-09-11T15:46:50-04:00September 11th, 2019|

Over the last few years, we have seen an increasing number of women with substance use disorders in our clinic. We are very excited that […]

Moving Forward with Brexanolone (Zulresso): Pilot Program at the Cleveland Clinic

MGH Center for Women's Mental Health2019-09-11T22:08:22-04:00September 10th, 2019|

It has been a few months since Zulresso (brexanolone), the new FDA-approved treatment for postpartum depression, has been available. At our clinic, we […]

Weekly Roundup for SEPTEMBER 6, 2019: Recent Publications in Women’s Mental Health

MGH Center for Women's Mental Health2019-09-09T15:23:22-04:00September 8th, 2019|

On this week’s list, we have multiple articles on the impact of perinatal mood and anxiety disorders on the pregnancy and on the […]

VIEW ALL RECENT BLOG POSTS

The National
Pregnancy Registry
for Psychiatric Medications:

All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry.

LEARN MORE

MGH Perinatal Depression Scale Mobile App

Are you pregnant? Do you own a smart phone? Get the MGH Perinatal Depression Scale app.

LEARN MORE

RESEARCH STUDIES

A Neurosteroid Intervention for Menopausal and Perimenopausal Depession

Are you experiencing symptoms of menopause and feeling depressed or down? You may be eligible for a research study at Massachusetts General Hospital evaluating how a medication treats menopausal depression and other symptoms of menopause.

National Pregnancy Registry for Psychiatric Medications©

The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, stimulants, and atypical antipsychotics that many women take during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders.

TO PARTICIPATE CALL TOLL-FREE:

1-866-961-2388

MGH Postpartum Psychosis Project (MGHP3)

If you are a mother who has experienced an episode of postpartum psychosis within the past ten years, you could help us to better understand this disorder. Researchers at Massachusetts General Hospital’s (MGH) Ammon-Pinizzotto Center for Women’s Mental Health are announcing the launch of a new research study called the MGH Postpartum Psychosis Project (MGHP3).

VIEW ALL